Oral Immunotherapy (OIT) for Food Allergy

Oral immunotherapy is a medically supervised treatment that uses carefully measured amounts of a confirmed food allergen with the goal of increasing the amount that triggers a reaction. OIT is not a cure, and patients continue prescribed avoidance, epinephrine access, and written dosing and emergency plans.

Clinic Information

Treatment Goals and Evidence

OIT goals, benefits, and expected results

What OIT can—and cannot—do

For some children with an IgE-mediated food allergy, oral immunotherapy may increase the reaction threshold while treatment continues. This can provide a margin of protection against some accidental exposures. Results differ by patient, allergen, age, protocol, and adherence.

OIT does not make an allergen unrestricted, eliminate anaphylaxis risk, or replace label reading, avoidance, epinephrine, or emergency planning. The decision to start should follow confirmation of the allergy and a detailed discussion of benefits, risks, alternatives, and the daily commitment involved.

Potential benefits

The principal potential benefit is a higher reaction threshold while treatment continues. For some families, that may reduce anxiety about small accidental exposures and make school, travel, and social activities easier to plan.

Benefit is not guaranteed. Reactions can still occur, and OIT does not prove that a patient can freely eat the allergen or that hospitalization or anaphylaxis cannot happen. Individual goals should be documented before treatment so progress can be evaluated realistically.

Expected results

Clinical studies show that OIT can desensitize some patients, but outcomes vary. Desensitization usually depends on continued exposure and is different from remission after treatment stops.

In the NIH-funded IMPACT trial of children ages 1–3 with peanut allergy, 71% of OIT participants met the study’s desensitization endpoint at the end of treatment, while 21% met its remission endpoint after six months of avoidance. Those trial results should not be used to predict the outcome for an individual child, another food, or a different clinical protocol.

Program video

Oral Immunotherapy Program Overview

A Carefully Measured Process

What Is Oral Immunotherapy?

Measured allergen dosing

OIT introduces a confirmed food allergen in small, measured amounts. Doses are increased only according to a clinician-directed protocol. The goal is desensitization: raising the amount of allergen that causes symptoms while treatment continues.

Program phases

A typical program includes an initial evaluation, confirmation of the food allergy, shared decision-making, supervised dosing or dose increases, daily home dosing, and ongoing maintenance. A food challenge may be recommended when the history and testing do not provide a clear diagnosis, but it is a separate supervised medical procedure.

Food Allergies Considered

Which Foods Can Be Evaluated for OIT?

Confirmed food allergy

Modena Health may discuss OIT protocols for peanut, tree nuts, milk, egg, sesame, wheat, and other foods when clinically appropriate. Available protocols, ages, foods, and treatment locations vary. The scheduling and clinical teams should confirm that an appropriate program is available before treatment is promised.

Program-specific availability

Skin or blood testing alone does not determine candidacy. The allergist also considers the reaction history, asthma control, gastrointestinal health, current avoidance plan, treatment goals, and the family’s ability to follow a daily protocol.

A Step-by-Step Care Plan

How Does an OIT Program Work?

Confirm the diagnosis. The allergist reviews the reaction history, prior testing, current avoidance, medications, and any previous emergency treatment. Additional targeted testing or a supervised food challenge may be recommended.
Review candidacy and alternatives. The family discusses expected benefits, known risks, daily responsibilities, other treatment choices, and what success would mean for that patient.
Begin under supervision. Initial dosing and designated dose increases take place in a clinical setting equipped to recognize and treat allergic reactions.
Continue the prescribed home dose. The patient takes only the exact amount and schedule in the written plan and follows the required observation, meal, activity, illness, and hot-water precautions.
Enter maintenance and follow-up. Once the planned maintenance dose is reached, continued dosing and follow-up are usually required to preserve desensitization.

Individual Assessment Matters

Who May Be a Candidate for OIT?

A potential candidate generally has a confirmed IgE-mediated food allergy and a family that can consistently follow daily dosing, monitoring, clinic visits, and emergency instructions.

The allergist will pay particular attention to asthma control; previous anaphylaxis; swallowing difficulty; persistent vomiting, reflux, chest pain, or abdominal pain; a history of eosinophilic esophagitis or another eosinophilic gastrointestinal disorder; and the ability to recognize and treat a reaction. No single skin-test result or blood-test value determines whether OIT is appropriate.

Daily Safety Is Part of Treatment

Home Dosing and Follow-Up

Give only the prescribed dose and never double, halve, skip, or restart a dose unless the written plan or care team specifically directs it.
Follow the protocol’s meal, observation, exercise, heat, and hot-shower restrictions.
Keep prescribed epinephrine immediately available and make sure caregivers know the emergency plan.
Contact the care team for missed doses, illness, fever, an asthma flare, a reaction, or uncertainty about dosing.
Report persistent swallowing trouble, vomiting, reflux, chest pain, or abdominal pain promptly.
Continue all scheduled follow-up visits and prescribed allergen avoidance.

Know When to Get Emergency Help

Urgent Safety Information

Possible anaphylaxis is an emergency. If a dose or exposure is followed by trouble breathing, wheezing, throat tightness, tongue or throat swelling, faintness, confusion, or rapidly developing symptoms in more than one body system, use prescribed epinephrine as directed in the patient’s action plan and call 911. Do not wait for a clinic callback or rely on antihistamines or an inhaler in place of epinephrine.

Patient Questions

Frequently Asked Questions

The goal is to increase the amount of a treated food needed to trigger symptoms while the patient remains on therapy. OIT is intended to provide a margin of protection from some accidental exposures, not unrestricted eating.

No. OIT is generally intended to produce desensitization, and continued maintenance dosing is often required. Patients still need prescribed avoidance, label reading, epinephrine, and an emergency action plan.

Studies show meaningful desensitization for some patients, particularly in research involving peanut, milk, and egg, but results vary substantially. Published averages cannot predict an individual patient’s response.

Reactions may include mouth itching, hives, swelling, abdominal pain, vomiting, wheezing, or anaphylaxis. Persistent gastrointestinal symptoms can require evaluation for an eosinophilic gastrointestinal disorder. The allergist should discuss patient-specific risks before treatment.

The dose-increase phase may take months, and maintenance can continue for years or longer. Timing depends on the allergen, protocol, reactions, missed doses, health changes, and treatment goals.

Follow the written protocol and contact the care team when required. Do not double, halve, or independently restart the dose. Resumption instructions depend on the protocol and the number of missed doses.

No, unless the treating allergist explicitly changes the plan after a supervised assessment. OIT does not remove the need for emergency preparedness.

Protocol availability depends on the food, patient age, health history, location, and clinician assessment. The care team should explain the proposed approach, whether it is FDA-approved or used off-label, and where each stage of care takes place.

Coverage varies by plan and by the services or products involved. Request a benefits review and ask about clinic charges, laboratory testing, supervised visits, and any non-covered treatment materials.

Choose the right next step

Contact Modena Health with a specific care question, or review clinic information before planning a visit.

Contact Modena Health Find a Location

Oral Immunotherapy (OIT) for Food Allergy

OIT goals, benefits, and expected results

What OIT can—and cannot—do

Potential benefits

Expected results

Oral Immunotherapy Program Overview

What Is Oral Immunotherapy?

Measured allergen dosing

Program phases

Which Foods Can Be Evaluated for OIT?

Confirmed food allergy

Program-specific availability

How Does an OIT Program Work?

Who May Be a Candidate for OIT?

Home Dosing and Follow-Up

Urgent Safety Information

Frequently Asked Questions

What is the goal of OIT?

Does OIT cure a food allergy?

How effective is OIT?

What are the risks of OIT?

How long does OIT take?

What should we do after a missed dose, illness, or asthma flare?

Can a patient stop avoiding the allergen or carrying epinephrine?

Which OIT protocols does Modena Health offer?

Does insurance cover OIT?

Related care guides

Food allergies

Oral food challenges

Food allergy testing

Choose the right next step